Clinical Trial Update: Breast Cancer Risk Assessment Using Optical Breast Spectroscopy (OBS)

View source ↗

Summary

The study evaluating optical breast spectroscopy as a risk assessment tool for breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University Health Network, Toronto | Conditions: Breast Cancer | Status: COMPLETED